FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application from Aurobindo Pharma Limited for clozapine, allowing the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)